With the introduction of tax reform this year, you may be looking at your finances and wondering how you can continue to be charitable. There are many ways you can make a difference at The Michael J. Fox Foundation while enjoying financial benefits for yourself.
Here are some smart ways to give in 2018:
Donate appreciated stock: With the stock market at or near all-time highs, give your appreciated stocks to a nonprofit like The Michael J. Fox Foundation and eliminate capital gains tax.
Name us as a beneficiary of retirement plan assets: These assets remain taxable when distributed to a loved one but are tax-free when given to a nonprofit.
Give from your IRA (if age 70½ or older): Regardless of whether you itemize your taxes, this gift helps you fulfill your required minimum distribution and is not considered taxable income.
Gifts of real estate: Many real estate markets are enjoying gains. Appreciated real estate may be subject to capital gains tax unless donated to charity or transferred to a charitable trust.
Talk With Your Tax Professional
Please consult with your tax or financial advisors to determine the best charitable giving strategies for you.
We are so grateful for your generosity. Please contact The Michael J. Fox Foundation at plannedgiving@michaeljfox.org or 212-509-1524 to discuss how your gift can help further our mission.
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.